Gastric Neoplasms

19 registered clinical trials studyying Gastric Neoplasms — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing NCT07312370	LanZhou University	Phase 4
Recruiting	Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies NCT04949737	University Hospital Center of Martinique	—
Recruiting	Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors NCT07001592	Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)	Phase 1
Recruiting	Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios NCT06848400	Nanfang Hospital, Southern Medical University	N/A
Completed	Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastr NCT04535414	National Cancer Institute (NCI)	Phase 2
Unknown	Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Adv NCT05111444	Fudan University	Phase 2
Active Not Recruiting	A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-posit NCT05152147	Jazz Pharmaceuticals	Phase 3
Recruiting	The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer NCT05551416	EDUARDO ALBENIZ	—
Withdrawn	Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer NCT04180761	University Hospital Tuebingen	Phase 2
Completed	Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse NCT03648879	National Cancer Institute (NCI)	Phase 2
Completed	Chromogranin A as Blood Marker in Cancer Patients NCT03817866	Brahms AG	—
Completed	Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive NCT03615326	Merck Sharp & Dohme LLC	Phase 3
Terminated	CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physicia NCT02900248	CureOne	—
Terminated	Efficacy and Safety Study of Pembrolizumab (MK-3475) Versus Paclitaxel in Asian Participants With Advanced Gas NCT03019588	Merck Sharp & Dohme LLC	Phase 3
Terminated	Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST) NCT02488746	Kliniken Ludwigsburg-Bietigheim gGmbH	—
Recruiting	Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer NCT01915225	National Cancer Institute (NCI)	—
Unknown	Clinical Impact of Second-look Endoscopy After Endoscopic Submucosal Dissection of Gastric Neoplasm NCT02005809	Kosin University Gospel Hospital	Phase 3
Completed	A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose NCT01614522	ASLAN Pharmaceuticals	Phase 2
Completed	A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma NCT01166490	Seagen Inc.	Phase 1